Search
15 result(s) for 'author#Federica Deodato' within BMC
Page 1 of 1
Sort by: Relevance | Date
-
Citation: The Journal of Headache and Pain 2017 18(Suppl 1):111
-
Proceedings of the International Scientific Conference AIFI 2017. Therapeutic Exercise: Foundations, Evidences and Clinical Reasoning in Physiotherapy Practice
Citation: Archives of Physiotherapy 2019 9(Suppl 1):17 -
Correction to: Clinical disease progression and biomarkers in Niemann–Pick disease type C: a prospective cohort study
An amendment to this paper has been published and can be accessed via the original article.
Citation: Orphanet Journal of Rare Diseases 2021 16:246 -
Orofacial features and pediatric dentistry in the long-term management of Infantile Pompe Disease children
Glycogen storage disease type II (GSDII) or Pompe disease is a rare autosomal recessive metabolic disorder that leads to intracellular glycogen storage in many tissues, mainly in skeletal muscle, heart and liv...
Citation: Orphanet Journal of Rare Diseases 2020 15:329 -
VARS2-linked mitochondrial encephalopathy: two case reports enlarging the clinical phenotype
Mitochondrial respiratory chain consists of five complexes encoded by nuclear and mitochondrial genomes. Mitochondrial aminoacyl-tRNA synthetases are key enzymes in the synthesis of such complexes. Bi-allelic ...
Citation: BMC Medical Genetics 2019 20:77 -
Enzyme replacement therapy: efficacy and limitations
Enzyme replacement therapy (ERT) is available for mucopolysaccharidosis (MPS) I, MPS II, MPS VI, and MPS IVA. The efficacy of ERT has been evaluated in clinical trials and in many post-marketing studies with a...
Citation: Italian Journal of Pediatrics 2018 44(Suppl 2):120 -
Long term clinical history of an Italian cohort of infantile onset Pompe disease treated with enzyme replacement therapy
Enzyme replacement therapy (ERT) has deeply modified the clinical history of Infantile Onset Pompe Disease (IOPD). However, its long-term effectiveness is still not completely defined. Available data shows a c...
Citation: Orphanet Journal of Rare Diseases 2018 13:32 -
Mis-splicing of the GALNS gene resulting from deep intronic mutations as a cause of Morquio a disease
Mucopolysaccharidosis-IVA (Morquio A disease) is a lysosomal disorder in which the abnormal accumulation of keratan sulfate and chondroitin-6-sulfate is consequent to mutations in the galactosamine-6-sulfatase (G...
Citation: BMC Medical Genetics 2018 19:183 -
Association of nutritional glycaemic indices with global DNA methylation patterns: results from the Moli-sani cohort
High dietary glycaemic index (GI) and load (GL) have been associated with increased risk of various cardiometabolic conditions. Among the molecular potential mechanisms underlying this relationship, DNA methyl...
Citation: Clinical Epigenetics 2022 14:189 -
Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival
To evaluate the impact of radiation dose on overall survival (OS) in patients treated with adjuvant chemoradiation (CRT) for pancreatic ductal adenocarcinoma (PDAC).
Citation: BMC Cancer 2019 19:569 -
Immune responses to alglucosidase in infantile Pompe disease: recommendations from an Italian pediatric expert panel
Classic infantile onset of Pompe disease (c-IOPD) leads to hypotonia and hypertrophic cardiomyopathy within the first days to weeks of life and, without treatment, patients die of cardiorespiratory failure in ...
Citation: Italian Journal of Pediatrics 2022 48:41 -
Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C
Twenty-five patients with Niemann Pick disease type C (age range: 7 months to 44 years) were enrolled in an Italian independent multicenter trial and treated with miglustat for periods from 48 to 96 months.
Citation: Orphanet Journal of Rare Diseases 2015 10:22 -
A new UHPLC-MS/MS method for the screening of urinary oligosaccharides expands the detection of storage disorders
Oligosaccharidoses are storage disorders due to enzymatic defects involved in the breakdown of the oligosaccharidic component of glycosylated proteins. The defect cause the accumulation of oligosaccharides (OS...
Citation: Orphanet Journal of Rare Diseases 2021 16:24 -
Clinical disease progression and biomarkers in Niemann–Pick disease type C: a prospective cohort study
Niemann–Pick disease type C (NPC) is a rare, progressive, neurodegenerative disease associated with neurovisceral manifestations resulting from lysosomal dysfunction and aberrant lipid accumulation. A multicen...
Citation: Orphanet Journal of Rare Diseases 2020 15:328 -
Open issues in Mucopolysaccharidosis type I-Hurler
Mucopolysaccharidosis I-Hurler (MPS I-H) is the most severe form of a metabolic genetic disease caused by mutations of IDUA gene encoding the lysosomal α-L-iduronidase enzyme. MPS I-H is a rare, life-threatening ...
Citation: Orphanet Journal of Rare Diseases 2017 12:112